Regression, Hand-Wringing, and Decelerating Head Growth
A 26-month-old girl is evaluated for loss of skills. She spoke 15 words and used a pincer grasp at 15 months; between 16 and 20 months she stopped using words, stopped reaching and grasping, and developed repetitive midline hand-wringing and hand-to-mouth movements. She walks with a wide-based gait and has staring episodes with lip smacking plus one two-minute episode of rhythmic arm jerking. Head circumference was at the 50th percentile at 12 months and is now at the 9th; height and weight track at the 25th. She has daytime hyperventilation spells that stop during sleep. Brain MRI at an outside hospital was read as normal. The family has been told she has 'autism with regression' and should start ABA. They ask whether further testing is worthwhile, in a 40-minute visit.
1. What diagnosis best accounts for this combination, and how do the specific features argue for and against the main alternatives?
Read the worked answer
Best fit: Rett syndrome. The core features align tightly:
- A period of apparently normal early development followed by loss of spoken words and loss of hand skills, not just language.
- Stereotyped midline hand-wringing and hand-to-mouth movements replacing purposeful hand use.
- Decelerating head growth while length and weight track normally, which is a distinctive pattern.
- Gait abnormality, seizures, and wake-only breathing dysrhythmia (hyperventilation that resolves in sleep).
Alternatives
- Childhood disintegrative disorder: regression typically begins after 2 years, with loss of social engagement and bowel/bladder skills, but without the hand stereotypies and decelerating head growth seen here.
- Landau-Kleffner syndrome: language regression with seizures and an abnormal EEG, but motor skills and head growth remain normal.
- Neuronal ceroid lipofuscinosis and other neurodegenerative disorders: regression with seizures fits, but vision loss, ataxia, and MRI changes usually appear; a normal MRI at this stage does not exclude an early stage.
- Autism with regression: does not explain loss of grasp, deceleration of head growth, or the breathing pattern. Labeling her now closes the diagnostic door prematurely.
2. What testing and referrals do you order, in what order, and what do you tell the family before testing?
Read the worked answer
Order now, do not wait for therapy to start
- MECP2 sequencing plus deletion/duplication analysis first line; it detects about 95% to 97% of classic Rett presentations. If negative, move to a broader neurodevelopmental or epilepsy gene panel (CDKL5, FOXG1, and related genes) or exome sequencing.
- Chromosomal microarray as a parallel or second-tier test; it is cheap, and findings change recurrence counseling even in the presence of a strong clinical diagnosis.
- Prolonged EEG (including sleep) to characterize staring spells and the arm-jerking episode, since epilepsy affects most girls with Rett; neurology referral for seizure management.
- Gastroenterology, orthopedics, and sleep follow-up for the complications that will emerge (constipation, reflux, scoliosis, sleep disturbance). No repeat MRI is needed now.
Pretest counseling: explain that MECP2 changes in classic Rett are almost always de novo, so recurrence risk is generally below 1%, with a small exception for parental germline mosaicism. Discuss possible variants of uncertain significance and the possibility of no result. Confirm insurance coverage for panel testing. Emphasize that a genetic result will not change her need for therapy but will change medical surveillance, prognosis, and family counseling.
3. How do you respond to the plan for ABA and to questions about prognosis and treatment?
Read the worked answer
On ABA: behavioral support is reasonable, but it should not be framed as treatment for autism and it must not delay etiologic workup. The evidence base for intensive early behavioral intervention in Rett syndrome specifically is thin. The highest-yield targets are functional communication (augmentative and alternative communication, eye gaze or switch access), hand-use preservation, and reducing hand-mouth behavior that interferes with function. Physical, occupational, and speech therapy are the backbone.
On prognosis: be honest and specific. This is a lifelong neurodevelopmental disorder with expected ongoing difficulties in communication, hand use, mobility, and seizures, but girls vary widely; some walk independently and use communication supports for years. Avoid both a catastrophic prediction and false reassurance.
On treatment: care is multidisciplinary and proactive: seizure control, treatment of constipation and reflux, scoliosis monitoring, sleep management, and attention to bone health. A disease-modifying medication (trofinetide) is approved in the United States for patients aged 2 years and older, with modest benefit and gastrointestinal side effects; discuss referral to a Rett center. Refer to a genetic counselor and to family support organizations, and screen the parents for caregiver strain.